China’s push to foster medical technology champions to rival US groups such as Elon Musk’s Neuralink is beginning to show results, with one Shanghai start-up moving to human trials within a few years of its founding.
manbetx3.0 正努力培育能与美国企业如埃隆•马斯克(Elon Musk)的Neuralink抗衡的医疗技术“冠军”，这一举措已开始见效：一家上海初创公司在成立数年内就推进至人体试验阶段。
您已阅读4%（304字），剩余96%（7267字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。